Yosemite is a venture capital firm established in 2023 and located in San Francisco, California. It focuses on investing in early-stage companies, primarily within the healthcare sector. The firm aims to support innovative businesses that have the potential to make significant impacts in their fields, leveraging its expertise and resources to foster growth and development.
Daymark Health is a company specializing in supportive care services for cancer patients. It connects primary care physicians, oncologists, and care teams to provide virtual and home-based care, focusing on symptom management, care navigation, social support, and mental health services. These services are delivered by nurse practitioners, social workers, and health partners, ensuring cancer patients receive comprehensive, personalized care addressing both medical and non-medical needs throughout their treatment journey.
Tune Therapeutics
Series B in 2025
Tune Therapeutics is focused on developing innovative cell and gene therapies that utilize epigenetic programming to address serious diseases. By harnessing the epigenome, the company aims to create new pathways for treatment without making changes to the DNA sequence itself. This approach allows for the potential development of therapies for complex and widespread medical conditions, positioning Tune Therapeutics at the forefront of advancements in the field of epigenetics.
Shinobi Therapeutics
Series A in 2024
Shinobi Therapeutics specializes in the development of cell therapies that leverage hypoimmune CD8αβ iPS-T cells to interact with the immune system for the treatment of cancer and various genetic diseases. The company's innovative approach incorporates advanced immune evasion technology to enhance the effectiveness and accessibility of these therapies. By focusing on durable responses and the potential for redosing, Shinobi aims to reduce costs and improve patient outcomes in the healthcare sector.
Turquoise Health
Series B in 2024
Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, Turquoise Health has developed a platform that enables users to browse and compare prices for elective services offered by hospitals. The platform facilitates price comparisons between various insurance services and allows individuals to search by procedure and provider. This innovative marketplace connects patients, providers, and payers, empowering individuals to save money on elective treatments while helping healthcare organizations attract both cash-paying and insured patients.
Maia Oncology
Seed Round in 2023
Maia Oncology is a virtual onco-primary care clinic that focuses on providing comprehensive care for cancer patients and survivors. The clinic operates a platform designed to coordinate cancer care, tracking important patient outcomes such as hospitalizations, emergency room visits, and the emergence of new comorbidities. This approach helps patients manage the complexities and long-term effects associated with cancer treatment. By offering a supportive environment, Maia Oncology aims to enhance the navigation of treatment-related challenges and improve overall patient well-being.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.